HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation.

Abstract
It is well-known that insoluble nickel compounds possess much more potent carcinogenic activities as compared with soluble nickel compounds. Although it is assumed that the different entry and clearance rate are responsible for the difference, the mechanisms underlying the different carcinogenic activities are still not well understood yet. In the present study, we found that exposure to soluble, but not insoluble nickel compounds, caused a significant inhibition of cell growth and G1/G0 cell cycle arrest, which was concomitant with a marked down-regulation of cylin D1, an essential nuclear protein for controlling G1/S transition, while both soluble and insoluble nickel compounds showed similar effects on NFkappaB activation, HIF-1alpha protein accumulation and TNF-alpha transcription and CAP43 protein expression at same doses range. The down-regulation of cyclin D1 is due to protein degradation rather than inhibition of transcription, because the nickel compounds treatment did not change cyclin D1 mRNA level, while MG132, the proteasome inhibitor, can rescue the degradation of cyclin D1 caused by soluble nickel compound. Moreover, the soluble nickel-induced cyclin D1 degradation is dependent on its Thr286 residue and requires IKKalpha, but not HIF-1alpha, which are both reported to be involved in cyclin D1 down-regulation. Taken together, we demonstrate that soluble, but not insoluble nickel compound, is able to cause cyclin D1 degradation and a cell growth arrest in an IKKalpha-dependent manner. Given the role of cyclin D1 and cell proliferation in carcinogenesis, we anticipate that the different effects of soluble and insoluble nickel compounds on cyclin D1 degradation and cell growth arrest may at least partially account for their different carcinogenic activities.
AuthorsWeiming Ouyang, Dongyun Zhang, Jingxia Li, Udit N Verma, Max Costa, Chuanshu Huang
JournalJournal of cellular physiology (J Cell Physiol) Vol. 218 Issue 1 Pg. 205-14 (Jan 2009) ISSN: 1097-4652 [Electronic] United States
PMID18792914 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright(c) 2008 Wiley-Liss, Inc.
Chemical References
  • CCND1 protein, human
  • Carcinogens
  • Ccnd1 protein, mouse
  • DNA Primers
  • Hif1a protein, mouse
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • RNA, Messenger
  • Cyclin D1
  • nickel chloride
  • Nickel
  • CHUK protein, human
  • Chuk protein, mouse
  • I-kappa B Kinase
  • nickel sulfide
  • nickel subsulfide
Topics
  • Animals
  • Base Sequence
  • Carcinogens (toxicity)
  • Cell Cycle (drug effects)
  • Cell Line
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Cyclin D1 (genetics, metabolism)
  • DNA Primers (genetics)
  • Down-Regulation (drug effects)
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (deficiency, genetics, metabolism)
  • I-kappa B Kinase (deficiency, genetics, metabolism)
  • Mice
  • Mice, Knockout
  • Nickel (toxicity)
  • RNA, Messenger (genetics, metabolism)
  • Solubility

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: